STAAR Surgical Company (STAA)

Receivables turnover

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue US$ in thousands 322,415 284,391 230,472 163,460 150,185
Receivables US$ in thousands 97,160 65,113 45,777 37,285 31,709
Receivables turnover 3.32 4.37 5.03 4.38 4.74

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $322,415K ÷ $97,160K
= 3.32

STAAR Surgical Company's receivables turnover has shown a fluctuating trend over the past five years. The ratio decreased from 4.74 in 2019 to 4.38 in 2020 before further declining to 5.03 in 2021. Subsequently, there was a notable drop to 4.37 in 2022, and the trend continued with a decrease to 3.32 in 2023.

A lower receivables turnover ratio indicates that the company is taking longer to collect payments from its customers, which may lead to a higher risk of bad debts or liquidity issues. This downward trend in receivables turnover could be a cause for concern, as it suggests an inefficiency in collecting outstanding receivables. Further analysis and monitoring of the company's accounts receivable management practices may be warranted to address this issue.


Peer comparison

Dec 31, 2023

Company name
Symbol
Receivables turnover
STAAR Surgical Company
STAA
3.32
National Vision Holdings Inc
EYE
24.50
The Cooper Companies, Inc. Common Stock
COO
5.43